LINC02864: A Potential Drug Target and Biomarker (G400655)

Target Name: LINC02864

NCBI ID: G400655

LINC02864

Other Name(s): Long intergenic non-protein coding RNA 2864 | long intergenic non-protein coding RNA 2864

LINC02864: A Potential Drug Target and Biomarker

LINC02864 is a long intergenic non-protein coding RNA (lncRNA) that has been identified in various studies as having potential drug targets and biomarkers. This RNA molecule has been shown to play a critical role in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation. In this article, we will provide a comprehensive overview of LINC02864, including its structure, function, and potential drug targets.

Structure and Function

LINC02864 is a 24.8 kilobase (kb) RNA molecule that contains 19 exons and 11 introns. It is characterized by a stem-loop structure that is composed of three conserved domains: a unique 5'-end domain, a conserved 3'-end domain, and a variable middle domain. The 5'-end domain is composed of 114 nucleotides and includes a unique open reading frame (ORF) that is specific to LINC02864. The 3'-end domain is composed of 199 nucleotides and includes a unique open reading frame (ORF) that is specific to LINC02864. The middle domain is composed of 454 nucleotides and includes a unique open reading frame (ORF) that is specific to LINC02864.

LINC02864 has been shown to play a critical role in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation. For example, LINC02864 has been shown to be involved in the regulation of cell cycle progression and cell apoptosis.

Potential Drug Targets

LINC02864 has been shown to be a potential drug target due to its involvement in the regulation of cellular processes that are important for human health. One potential mechanism by which LINC02864 could be targeted is through its role in the regulation of cell apoptosis. LINC02864 has been shown to play a critical role in the regulation of cell apoptosis, which is a natural process that helps to remove damaged or dysfunctional cells from the body.

In addition to its role in cell apoptosis, LINC02864 has also been shown to play a critical role in the regulation of cell cycle progression. LINC02864 has been shown to be involved in the regulation of microtubule dynamics and stability, which are important for the proper functioning of the cell cycle.

Potential Biomarkers

LINC02864 has also been shown to be a potential biomarker for various diseases, including cancer. For example, LINC02864 has been shown to be involved in the regulation of cell apoptosis in cancer cells, which could make it an attractive target for cancer therapies.

Conclusion

In conclusion, LINC02864 is a long intergenic non-protein coding RNA that has been shown to play a critical role in the regulation of various cellular processes. Its unique structure and function make it a potential drug target and biomarker. Further research is needed to fully understand the role of LINC02864 in cellular processes and its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2864

The "LINC02864 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02864 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets